Anzeige
Mehr »
Donnerstag, 10.09.2026 - Börsentäglich über 12.000 News
Mehr als 4,5 Mrd. USD US-Staatsgeld für alte Bohrlöcher, diese Aktie räumt auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
113 Leser
Artikel bewerten:
(0)

Vheda Health Secures $47 Million Investment from Agora to Scale Outcomes and Analytics Platform for Health Plans

First institutional capital in Vheda's 13-year history and the inaugural investment for Agora, the healthcare technology investment firm founded by Neil Vangala

COLUMBIA, MD / ACCESS Newswire / September 10, 2026 / Vheda Health, an outcomes and analytics company serving health plans' highest-risk and hardest-to-reach members, today announced a $47 million investment from Agora, a San Francisco-based private equity investment firm focused on healthcare and life science technology. The investment, which represents the first institutional capital in Vheda's 13-year history and the inaugural investment for Agora, will fund Vheda's continued national expansion across health plans and geographies, new product and analytics capabilities, and targeted acquisitions.

Founded in 2013 and bootstrapped by CEO & Co-Founder Shameet Luhar and Philip Rub, Vheda provides health plans with an outcomes and analytics platform that continuously captures member-level clinical and behavioral data, identifies and stratifies high-risk members, and triggers interventions before costly events occur. The platform's analytics drive condition-specific engagement workflows, with clinical care teams acting on its signals to close the loop with providers and health plans. Unlike point solutions that stop at monitoring, Vheda's model turns engagement into measurable behavior change and lowers medical costs, while building a longitudinal data asset on each plan's hardest-to-reach members. The Company serves all major MCOs and health plans nationally and has generated more than $975 million in savings for its health plan partners.

Across its chronic and maternity programs, Vheda delivers 80%+ average monthly active engagement and an average 3:1 return on investment, driven by reductions in avoidable emergency room and inpatient utilization and improvements in health plan quality measures. In maternity, Vheda members average a gestational age at delivery of 38.4 weeks, a NICU admission rate below 8%, and approximately 20% lower delivery costs. The Company's purpose-built data collection and analytics also allow health plans to deploy human- and AI-led analytics and cost-containment programs across large and diverse populations.

Shameet Luhar will continue to lead Vheda as CEO, supported by a team of more than 110 health specialists, data scientists and analytics experts.

"Vheda was built on a simple premise: when you make healthcare easier for people to navigate, you can quantify and activate even the hardest-to-reach populations and fundamentally change their health and cost trajectory," said Shameet Luhar, CEO and Co-Founder of Vheda Health. "We have spent thirteen years proving that activation translates into measurable, defensible outcomes including more than $975 million in savings for our health plan partners and better lives for the members we serve. Agora's investment allows us to bring that model to significantly more health plans and members nationwide. We believe the future of healthcare will be defined by outcomes, not by the number of point solutions deployed."

"Vheda is exactly the kind of business we started Agora to back: a founder-built company that has proven it can activate the hardest-to-reach members in healthcare and bend their cost and outcomes trajectory," said Neil Vangala, Managing Partner of Agora. "Without institutional capital, Shameet and his team built a platform that health plans trust with their most complex populations. We are excited to provide the financial resources as well as the commercial support and M&A guidance to build Vheda into a category-defining player."

Miles & Stockbridge served as legal counsel to Vheda Health. DLA Piper served as legal counsel to Agora.

About Agora

AGA Manco LP and its affiliates ("Agora") is a San Francisco-based investment firm that makes concentrated investments in healthcare and life science technology companies, with a focus on founder-owned businesses and venture-backed companies seeking a new path to growth. Agora generally invests $30-60 million of equity per company and pairs its capital with hands-on go-to-market, leadership and M&A support. The firm was founded in 2026 by Neil Vangala, previously a Managing Director at Eir Partners. For more information, visit agoracap.com.

About Vheda Health

Vheda Health is an outcomes and analytics company that partners with health plans to identify and activate their highest-risk, hardest-to-reach members and deliver measurable improvements in medical cost, utilization, quality and clinical outcomes. Founded in 2013 and headquartered in Columbia, Maryland, Vheda delivers more than 80% average monthly member engagement and an average 3:1 return on investment across its chronic care and maternity programs and has generated more than $975 million in savings for its health plan partners through a closed-loop model combining technology, analytics, connected devices and culturally responsive human support.

For more information, watch Vheda's two-minute explainer video at The Vheda Blueprint, visit vheda.com, or follow Vheda Health on LinkedIn.

Media Contact

Kerry Lee Perry
Chief Marketing Officer
Vheda Health
kperry@vheda.com
404-849-1380

SOURCE: Vheda Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/vheda-health-secures-47-million-investment-from-agora-to-scale-outcom-1218657

© 2026 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.